488 related articles for article (PubMed ID: 28356013)
1. Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones.
Yamali C; Gul HI; Ozgun DO; Sakagam H; Umemura N; Kazaz C; Gul M
Anticancer Agents Med Chem; 2017; 17(10):1426-1433. PubMed ID: 28356013
[TBL] [Abstract][Full Text] [Related]
2. 1-(3-aminomethyl-4-hydroxyphenyl)-3-pyridinyl-2-propen-1-ones: a novel group of tumour-selective cytotoxins.
Bilginer S; Gul HI; Mete E; Das U; Sakagami H; Umemura N; Dimmock JR
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):974-80. PubMed ID: 22803675
[TBL] [Abstract][Full Text] [Related]
3. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of some acrylophenones with N-methylpiperazine and evaluation of their cytotoxicities.
Gul HI; Tugrak M; Sakagami H
J Enzyme Inhib Med Chem; 2016; 31(1):147-51. PubMed ID: 25697271
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases.
Yamali C; Gul HI; Sakagami H; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(sup4):125-131. PubMed ID: 27594305
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Structure-Cytotoxicity Relationship of Chalcones.
Sakagami H; Masuda Y; Tomomura M; Yokose S; Uesawa Y; Ikezoe N; Asahara D; Takao K; Kanamoto T; Terakubo S; Kagaya H; Nakashima H; Sugita Y
Anticancer Res; 2017 Mar; 37(3):1091-1098. PubMed ID: 28314269
[TBL] [Abstract][Full Text] [Related]
10. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
[TBL] [Abstract][Full Text] [Related]
11. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
Alswah M; Bayoumi AH; Elgamal K; Elmorsy A; Ihmaid S; Ahmed HEA
Molecules; 2017 Dec; 23(1):. PubMed ID: 29280968
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and
Alimujiang Y; Maimaiti A; Ablise M; Yang Z; Liu Z; Wang Y; Mutalipu Z; Yan T
Anticancer Agents Med Chem; 2024; 24(6):423-435. PubMed ID: 38204258
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Evaluation of Heterocycles Based Chalcone Derivatives as Antiproliferative Agents.
Çavuşoğlu BK; Atlı Ö; Görmüş G; Özkay Y; Kaplancıklı ZA
Anticancer Agents Med Chem; 2018; 18(7):1044-1053. PubMed ID: 29308744
[TBL] [Abstract][Full Text] [Related]
17. Anthraquinone-chalcone hybrids: synthesis, preliminary antiproliferative evaluation and DNA-interaction studies.
Marković V; Debeljak N; Stanojković T; Kolundžija B; Sladić D; Vujčić M; Janović B; Tanić N; Perović M; Tešić V; Antić J; Joksović MD
Eur J Med Chem; 2015 Jan; 89():401-10. PubMed ID: 25462255
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of mono Mannich bases of 2-(4-hydroxybenzylidene)-2,3-dihydroinden-1-one and evaluation of their cytotoxicities.
Tugrak M; Yamali C; Sakagami H; Gul HI
J Enzyme Inhib Med Chem; 2016 Oct; 31(5):818-23. PubMed ID: 26247355
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
